Safety and Immunogenicity of the Recombinant BCG Vaccine AERAS-422 in Healthy BCG-naïve Adults: A Randomized, Active-Controlled, First-In-Human Phase 1 Trial
EBioMedicine - Netherlands
doi 10.1016/j.ebiom.2016.04.010
Full Text
Open PDFAbstract
Available in full text
Date
May 1, 2016
Authors
Publisher
Elsevier BV